Although previous studies have already identified elevated AFP to be a robust predictor of poor survival for HCC [10], and CLIP staging system also allocated AFP > 400 ng/mL to be an independent prognostic indicator [11], no studies so far have analyzed the clinical features or survival outcome of N-HCC after hepatectomy. This evidence concerns the gene AFP and hepatocellular carcinoma.